Scouting report · OPCH
John C. Rademacher
Ran Option Care before its 2019 BioScrip merger; CEO of the combined company since
- Born / age
- (59)
- Role
- President & Chief Executive Officer; director
- In the role
- 7 yr
- Education
- BA Hillsdale College
- Front Office rank
- not ranked yet
OPCH
Option Care Health, Inc.Healthcare services
- Title
- President & Chief Executive Officer; directorsrc
- In role
- since 2019-08 (7 yr)
Stake value—no holding or price on file
—thin record
Scouting sheetas of 25 Sep 2026
Delivers guidance—no promises on the record yet
Answers the question—no call reviewed yet
Capital allocation—company not reviewed yet
Pay design6588% performance-conditioned · ebitda, revenue, individual, eps, time only · 97.1% for · 4.46% of net income
Skin in the game—no holding or price on file
—Hit rate
88%Pay at risk
97%Say-on-pay
—Airtime on calls
- Beat
- 0
- Met
- 0
- Missed
- 0
- Withdrawn
- 0
- Still open
- 0
- Answers on calls
- 0
- Questions dodged
- 0
- Dodges / 100 answers
- —
Personal and ownership data
Not on file yet: born, place of birth, citizenship, marital status.
What to weigh
Watch 5
- FY2026 revenue guidance of $5.8-6.0bn, issued 2026-02-24, was cut to $5.675-5.775bn on 2026-04-30. Q1 revenue grew 1.3% and adjusted EBITDA fell 6.3%, and he said the company was not satisfied with its revenue growthsrc
- On 2026-07-29 the adjusted EBITDA range was narrowed to $480-495m (top end down from $505m) while the revenue range was held; Q2 revenue grew 1.9%src
- Only 50.6% of votes backed say-on-pay in 2024. The company blamed one-time supplemental equity grants and cash awards tied to the terminated Amedisys deal in 2023, the year his reported pay was $16.6m including $5.1m of optionssrc
- PSUs pay 75% on three-year adjusted EPS and 25% on revenue and adjusted EBITDA growth; the targets are not disclosed. His bonus target rose from 130% to 150% of salary in 2025src
- Senior team turnover: CFO Michael Shapiro handed over to Meenal Sethna on 2025-10-01 and the Chief Growth Officer left on 2026-05-08src
In their favour 2
Pay
Salary and otherBonus, stock, options, incentive
The table
- Bonus pays on
- MIP target 150% of salary behind an Incentive EBITDA funding gate ($444.15m): 50% adjusted EBITDA (target $465m, actual $471.3m), 30% revenue (target $5,334m, actual $5,649.5m), 20% individual; formula paid 110% of target, his award $1.665m
- Long-term award pays on
- $6.5m target: 60% PSUs (three-year cumulative adjusted EPS 75%, average revenue and adjusted EBITDA growth 25%; 0-200%, targets undisclosed) and 40% RSUs vesting a third a yearsrc
- Pay at risk 88% performance-conditioned
- Pays on returns ebitda, revenue, individual, eps, time only
- Shareholder vote 97.1% for
- Pay vs profit 4.46% of net income
CEO pay ratio 167 : 1
Career
- 2019 – nowOption Care Health (listed; formerly BioScrip)src
President & CEO; director
Appointed 2019-08-06 on completion of the Option Care / BioScrip merger - 2017 – 2019Option Care (private)src
Chief Executive Officer (interim at first); director from 2018
DEFM14A-2019 says CEO since August 2017; DEF14A-2026 lists 'President and CEO, 2018-present' and 'COO 2015-2018' - 2015 – 2017
- 2012 – 2014
- 2007 – 2012
- 2001 – 2007CIGNAsrc
Executive roles incl. President of CareAllies, LLC and COO of CIGNA Behavioral Health business units
Undated in the sources
- Deloitte Consultingsrc, Strategy consultant
Not located: 2014-2015 between Cardinal Health and Option Care not described in any source read; years at Deloitte Consulting not stated
The promise ledger
No promise on the record yet: the research routine has not scored this company's guidance.
Background
- Family The 2026 proxy states there are no family relationships among the executive officers and directorssrc
- Boards Director of Thrivent Financial for Lutherans, a privately held financial services company; no other public-company boardsrc
- Other Holds an employment agreement signed before the 2019 merger (confidentiality, non-solicit, non-compete). In February 2024 he gave up its severance terms and moved to the Executive Severance Plansrc
- Other Recommends pay for the other named executives; his own pay is set by the independent directors without him presentsrc
Sources12
- Filing Option Care Health DEF 14A (accession 0001140361-26-013825) · 2026-04-08
- Filing Option Care Health DEF 14A (accession 0001140361-25-011852) · 2025-04-02
- Filing Option Care Health 8-K Item 5.07, 2026 annual meeting results (0001014739-26-000017) · 2026-05-22
- Filing BioScrip DEFM14A for the Option Care merger, 'Biographies of Option Care Designated Directors' (0001144204-19-032467) · 2019-06-26
- Filing Option Care Health (formerly BioScrip) 8-K Item 5.02, officers of the combined company (0001144204-19-038051) · 2019-08-07
- Filing Option Care Health 8-K Ex. 99.1, Q4/FY2025 results and FY2026 guidance (0001014739-26-000005) · 2026-02-24
- Filing Option Care Health 8-K Ex. 99.1, Q1 2026 results and updated FY2026 guidance (0001104659-26-052099) · 2026-04-30
- Filing Option Care Health 8-K Ex. 99.1, Q2 2026 results and updated FY2026 guidance (0001014739-26-000021) · 2026-07-29
- Filing Option Care Health 8-K Item 5.02, Chief Growth Officer departure (0001014739-26-000014) · 2026-05-05
- Filing SEC XBRL companyfacts us-gaap/NetIncomeLoss, CIK 1014739 (FY2025 10-K, 0001014739-26-000008) · 2026-02-24
- Filing Form 4, John Charles Rademacher (reporting CIK 1779969), open-market purchase of 2026-05-04 (0001437749-26-014692) · 2026-05-04
- Filing Form 4, John Charles Rademacher, shares withheld for tax on 2026-02-20/22 vestings (0001437749-26-005408) · 2026-02-24